MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1161/01.str.0000152331.93770.18

Медицинская библиотека · Stroke · 2004

Aggressive mechanical clot disruption: a safe adjunct to thrombolytic therapy in acute stroke?

Noser Elizabeth A, Shaltoni Hashem M, Hall Christiana E, Alexandrov Andrei V, Garami Zsolt, Cacayorin Edwin D, Song Joon K, Grotta James C, Campbell Morgan S

СтатьяПоддержка NIH: внешняя программаПоддержка службы здравоохранения СШАПеревод пока не подготовлен

Аннотация

BACKGROUND AND PURPOSE: This study evaluated the safety and efficacy of aggressive mechanical clot disruption (AMCD) in acute stroke patients with persisting middle cerebral artery (MCA) or internal carotid artery (ICA) occlusion after thrombolytic therapy.

METHODS

Retrospective case series were used from a prospectively collected stroke database on consecutive acute ischemic stroke patients treated with intra-arterial (IA) thrombolytics and mechanical clot disruption during a 5-year interval. Thrombolytic dosage, endovascular techniques, immediate and final recanalization rates, symptomatic hemorrhage, mortality, and outcome were determined.

RESULTS

Thirty-two patients received AMCD. Median baseline National Institutes of Health Stroke Scale (NIHSS) score was 18, and median time to initiation of IA treatment was 261 minutes from symptom onset. ICA occlusion was noted in 16 patients and MCA occlusion in 16 patients: 22 received combined IV/IA thrombolytics, 3 received IV thrombolytics, 6 received IA thrombolytics, and 1 patient received no thrombolytics before AMCD. No immediate periprocedural complications were noted. Immediate recanalization was achieved in 38% (50% MCA, 25% ICA) and final recanalization in 75% (88% MCA, 63% ICA) of patients. Favorable outcome occurred in 19 (59%) patients, symptomatic cerebral hemorrhage in 3 (9.4%) patients, and mortality in 4 (12.5%) patients.

CONCLUSIONS

AMCD can be performed safely with comparable intracerebral hemorrhage and mortality rates to other IA therapies even after use of intravenous thrombolytics in selected patients. Early deployment of this technique leads to immediate recanalization in one third of patients. AMCD may potentially shorten the time to flow restoration and improve overall recanalization rates achieved with IA therapy.

Для цитирования: Noser Elizabeth A, Shaltoni Hashem M, Hall Christiana E, Alexandrov Andrei V, Garami Zsolt, Cacayorin Edwin D, Song Joon K, Grotta James C, Campbell Morgan S. Aggressive mechanical clot disruption: a safe adjunct to thrombolytic therapy in acute stroke?. Stroke. 2004. DOI: 10.1161/01.str.0000152331.93770.18.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.